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Abstract 35 
 36 
Objective  37 
To estimate excess mortality and life-years lost in a Swiss cohort of individuals with traumatic spinal 38 
cord injury (TSCI). 39 
Methods   40 
This study uses population-based data collected in the Swiss Spinal Cord Injury Cohort (SwiSCI) 41 
study, which covers all specialized rehabilitation centers. Flexible parametric survival models were 42 
used to model life years remaining (LYR), potential years life lost (PYLL), relative survival and excess 43 
hazard ratios. 44 
Results 45 
Men and women with TSCI and an attained age of 30, were estimated to have 42 LYR (95% CI=37.9-46 
45.5) and 43 LYR (95% CI=40.1-45.5), respectively; this equates to a life expectancy (LE) of 80.6% 47 
and 76.9% of that of the Swiss general population. With respect to lesion level and completeness, 48 
persons with incomplete paraplegia had 45.1 LYR at an attained age of 30, whereas individuals with 49 
complete tetraplegia only had 28.7 LYR. This pattern was similar for PYLL.  50 
Conclusion 51 
The extended LE following TSCI, even for the most severe lesions, underscores the need for 52 
sustained follow-up to support functioning and health for individuals aging with SCI.53 
Introduction 54 
The 2017 Global Burden of Disease (GBD) report identified non-communicable diseases (NCDs) as 55 
the leading contributor to mortality as well as to disability-adjusted life years (DALYs), a 56 
comprehensive measurement of disease burden that has globally seen a 40% increase between 1990 57 
and 2017 (Cao et al. 2018; GBD 2017 DALYs and HALE Collaborators 2018). While previous GBD 58 
reports have reported positive trends of improved health and life expectancy virtually universally, the 59 
recent 2017 report presents a sobering picture with reductions in progress towards improved health, 60 
and projected escalations in the burden of disease due to NCDs (Cao et al. 2018; GBD 2017 DALYs 61 
and HALE Collaborators 2018). To curb this trend, it is necessary to quantify the burden of disease in 62 
order to set priorities for resource management and targeting improvement. To this aim, estimates of 63 
life expectancy or potential years of life lost are important parameters of individual and societal 64 
burden. These indicators evaluate the integral impact of health conditions or health states on human 65 
functioning insomuch as they serve as a censor, aid in planning of resources and service needs, and 66 
contribute to the evaluation of DALYs (2018). Additionally, relative measures – including relative 67 
survival or excess mortality – can be used to account for background mortality in the general 68 
population in order to quantify the true impact of spinal cord injuries (SCIs) on risk of premature 69 
mortality.  70 
Traumatic spinal cord injuries (TSCIs) are a non-communicable, neurological condition with 71 
lifelong implications including reduced well-being, increased morbidity and mortality, and a generally 72 
high individual and societal economic burden (WHO 2013). Albeit rare, the individual impact of TSCIs 73 
on mortality risk is similar to other chronic conditions (e.g., multiple sclerosis). For instance, persons 74 
with a TSCI experience mortality rates more than double that of the general population (Standardized 75 
mortality ratio [SMR]=2.32; 95% CI=2.10-2.56), similar to that of multiple sclerosis (SMR=2.7; 95% 76 
CI=2.4-3) or traumatic brain injury (SMR=2.25; 95% CI=2.1-2.4) (Lunde et al. 2017; Chamberlain et al. 77 
2019; Harrison-Felix et al. 2012). Further contributing to the burden associated with TSCIs, in addition 78 
to the burden attributed to premature mortality, TSCIs are associated with a high disability weight in 79 
DALY calculations, thereby directly implicating a higher burden given the impact on years lived with 80 
disability (Salomon et al. 2015). However, the available evidence of burden is limited; particularly 81 
within the Swiss context. Therefore, the purpose of this study is to provide Swiss-specific estimates of 82 
life expectancy, life years lost, excess mortality and relative survival.  83 
 84 
Methods 85 
Study population 86 
This study uses data collected from the Swiss Spinal Cord Injury Cohort (SwiSCI) study (Post et al. 87 
2011; Chamberlain et al. 2017). Data on vital status have been further enhanced through probabilistic 88 
record linkage with the Swiss National Cohort (SNC) to obtain cause of death and additional 89 
sociodemographic variables (e.g., marital status). This has been previously described in detail  90 
(Chamberlain et al. 2019). The SwiSCI study includes all persons admitted to one of the five 91 
specialized rehabilitation centers (currently four active) within Switzerland for first rehabilitation 92 
following SCI. Importantly, individuals who died before admission to first rehabilitation are therefore not 93 
included within the SwiSCI study. Individuals with cauda equina lesions, which are peripheral lesions 94 
with a differential impact on prognosis and evolution of SCI-specific secondary health conditions, as 95 
compared to non-peripheral lesions of the spinal cord, were excluded from all analyses (N=150). To 96 
ascertain vital status, a comprehensive follow-up was recently undertaken for individuals injured 97 
between 1990 and 2011; the present study is thus restricted to those individuals who sustained a 98 
traumatic SCI, and were included within the vital status update. Individuals were considered lost to 99 
follow-up (LTFU) if information on vital status at study end (administrative censoring date: September 100 
30, 2011) was unavailable even after active follow-up through participating clinics and municipalities. 101 
This has been described in further detail previously (Buzzell et al. 2018; Chamberlain et al. 2018). 102 
Information on mortality in the Swiss general population (GP) was acquired through the Swiss Federal 103 
Statistical Office (Neuchâtel), including information on the mortality rate, number of deaths and time-104 
at-risk according to age, sex, and calendar year.  105 
 106 
Statistical analysis 107 
For this study, level and completeness of the spinal cord lesion were grouped together into a four-level 108 
variable, including: paraplegia incomplete; paraplegia complete; tetraplegia incomplete; tetraplegia 109 
complete. Age was included as a categorical variable according to ISCoS guidelines to ensure 110 
comparability with previous research (DeVivo et al. 2011). For the estimation of excess mortality rate 111 
ratios (eHRs) and relative survival we used splitting techniques to partition follow-up time of individuals 112 
with SCI with respect to age class and year, thus facilitating proper benchmarking to the mortality data 113 
of the GP by age, sex, and calendar year. Given the high mortality rate during the months immediately 114 
following injury, estimates were restricted to individuals that survived at least six months post -injury. 115 
GP mortality rates – stratified by age, sex, and year of death – were merged with attained age, sex, 116 
and attained year of death of the SCI cohort. This was similarly performed for estimation of potential 117 
years life lost (PYLL), with the exception that age and year at injury were used in place of attained age 118 
and year. 119 
 120 
Time-at-risk started with date of SCI, with study start on date of admission to first rehabilitation. 121 
Individuals exited the study on date of death or end of study (September 30, 2011), whichever came 122 
first. Individuals LTFU were censored on last date of known vital status. To prevent over-123 
parameterization of models, confounders were identified using directed acyclic graphs (DAGs) 124 
informed by theory, previous evidence, and data availability; included confounders were: age, sex, 125 
level and completeness of lesion (Greenland et al. 1999). Excess mortality and relative survival were 126 
modelled using a flexible parametric survival model (FPM) (Dickman and Coviello 2015). The 127 
Bayesian Information Criterion (BIC) value was used to identify best -fitting models given the degrees 128 
of freedom (df); 3 df were determined for best fit. The proportional hazards assumption was assessed 129 
using a likelihood ratio test comparing models with and without inclusion of time-dependent effects. A 130 
FPM was used to predict life years remaining (LYR) using restricted mean survival time at attained 131 
ages: 30; 40; 50; and 60 years of age. A maximum attained age of 90 years, which is close to the 132 
oldest ages observed in the study population was used in modelling. A FPM was similarly used to 133 
model the PYLL; level and completeness of injury, age at injury as a continuous variable using splines, 134 
and sex were controlled for in the model. Pre-2000, information on the American Spinal Injury 135 
Association (ASIA) Impairment Scale (AIS) score (Roberts et al. 2017) was not regularly collected, 136 
estimates stratified by injury severity (a combination of AIS score and level of lesion) thereby exclude 137 
individuals who incurred a TSCI pre-2000. Hazard ratios (HRs) and excess hazard ratios (eHRs) were 138 
modelled using a FPM, and are presented with 95% confidence intervals. Excess hazard ratios and 139 
standard HRs can be interpreted similarly, with the addition that eHRs account for variation in the 140 
background mortality rates of the GP. For example, an eHR of 1.2 for males relative to females would 141 
indicate that males have a 20% higher risk of mortality after controlling for the background variation in 142 
GP mortality. 143 
 144 
All analyses were carried out using Stata version 14.2 (StataCorp 2015), and all figures were created 145 
using SigmaPlot (Systat Software, San Jose, CA). 146 
 147 
Results 148 
This study includes 2’492 individuals, of which 379 (15.2%) had a known date of death. Of those 149 
individuals that died, 149 (39.3%) died within the first two years post-injury, 87 (23.0%) between two 150 
and five years, 81 (21.4%) between five and ten years, and 62 (16.4%) between 10 and 21 years. 151 
Additionally, more than half were male (68.6%), nearly two thirds of the population were over the age 152 
of 60 years at time of death (60.1%), and roughly 40% had an incomplete tetraplegia (Table 1).  153 
 154 
Life years remaining and potential life years lost 155 
Estimated life years remaining (LYR) according to study characteristics are presented in Table 2. No 156 
notable differences in residual life expectancy (LE) were identified between men and women. For 157 
example, men with an attained age of 30 had an estimated 42 LYR (95% CI=37.9-45.5), while women 158 
had an estimated 43 LYR (95% CI=40.1-45.5) (Table 2). However, in comparison to the GP, men and 159 
women with an attained age of 30 years experienced a LE of roughly 80.6% and 76.9% compared to 160 
that of the Swiss GP (data not shown) (2017). The number of LYR was influenced by completeness 161 
and level of lesion. For example, with an attained age of 30 years, persons with incomplete paraplegia 162 
had 45.1 LYR, whereas individuals with complete tetraplegia only had 28.7 LYR, equating to 53.9% of 163 
the LE of the GP (Table 2).  164 
 For individuals injured between 1990 and 2011, there is an estimated total of 8’486.5 PYLL 165 
due to TSCI; of which 75% is attributable to TSCIs incurred between 16 and 45 years of age. Figure 1 166 
provides a visualization of PYLL according to lesion characteristics across different ages at injury. 167 
Individuals with incomplete and complete paraplegia as well as with incomplete tetraplegia exhibited 168 
similar PYLLs, with an average estimated PYLL at 20 years of 4.4, 5.9, and 4.8, respectively (Figure 169 
1). In comparison, a complete tetraplegia incurred at 20 years of age, reduced LE by nearly 14 years 170 
(Figure 1). This gap in PYLL according to lesion level and completeness persisted across differing 171 
ages at injury.  172 
 173 
Relative survival and excess mortality 174 
Estimated excess mortality per 1’000 persons-years is provided in Table 3. Across sociodemographic 175 
characteristics, excess mortality is impacted by lesion level and completeness. For example, the 176 
excess mortality rate for individuals aged between 16 and 30 years old with an incomplete paraplegia 177 
was 0.6 (95% CI=0.15-2.04) per 1’000 person-years, while for individuals with complete tetraplegia the 178 
excess mortality was roughly four additional deaths per 1’000 person-years (95% CI=1.07-11.98) 179 
(Table 3). This divergence increased with age. A comparison of HRs and eHRs is presented in Figure 180 
2. When accounting for background mortality in the GP, effect sizes for the 31-45 year old age group 181 
increased slightly, while eHRs for the oldest age group were attenuated, accounting for the higher risk 182 
of mortality with older ages experienced by the general population (Figure 2). Differences in risk of 183 
mortality according to lesion level and completeness were similarly exaggerated when accounting for 184 
background GP mortality rates, with an excess mortality rate nearly seven-fold higher for individuals 185 
with complete tetraplegia in comparison to persons with incomplete paraplegia (eHR=6.78; 95% 186 
CI=3.29-13.93) (Figure 2). Comparisons of standard survival estimates and relative survival estimates 187 
demonstrate the mortality attributable to TSCI by accounting for the expected mortality among persons 188 
with SCI, estimated from age- and sex- stratified mortality rates in the GP (Figure 3). For example, 189 
individuals with a complete tetraplegia who survived at least half a year post -injury had an estimated 190 
10-year survival probability of roughly 75% (Figure 3). When accounting for background mortality rates 191 
in the GP, relative survival estimates showed that excluding the possibility of mortality due to any other 192 
disease or external factor, 20% of persons with complete tetraplegia will have died due to their 193 
diagnosis 10 years post-injury (Figure 3).  194 
 195 
Discussion 196 
Summary 197 
In Switzerland, persons with a traumatic SCI and an attained age of 30 years have an estimated 28.7 198 
to 45.1 years of life remaining with higher, more severe injuries equated with the greatest reductions in 199 
residual life expectancy. Additionally, although older age is associated with a higher risk of mortality, 200 
this study found that individuals injured at a younger age lost substantially more life years. Finally, this 201 
study revealed that the risk of mortality following TSCI remains elevated across the life course of the 202 
spinal cord injured individual, never returning to that of the general population.  203 
 204 
In the present study, the LE for individuals with a TSCI and an attained age of 30 years old varied 205 
between 53.1% and 88.0% of the LE of the Swiss general population (2017). Our results contribute to 206 
consistent evidence in high income countries. For example, a study using data from the Model 207 
Systems in the United States, estimated the LE for 25 year old white males, with an elapsed time of 208 
three years since incurring a TSCI, to be between 52% and 88% that of the general population LE, 209 
depending on lesion level and severity (Shavelle et al. 2015). Similarly, in a United Kingdom-based 210 
study by Savic et al, the estimated LE after TSCI was between 57.1% and 86.9% of that of the general 211 
population for men with an attained age of 25 years, who survived at least one-year post-injury 212 
(excluding ventilator-dependent persons) (Savic et al. 2017). To note, both of these studies also 213 
investigated trends in LE among individuals with TSCI and found either minimal or no improvement LE 214 
across recent decades. This suggests that while the LE of the GP has been steadily improving across 215 
high-income countries, improvements in long-term survival for individuals with SCI have remained 216 
largely stagnant. Such reductions and lack of improvement in LE in comparison to the general 217 
population are indicative of the large burden on the individual.  218 
This study found that although older individuals are at a higher risk of mortality, individuals  who 219 
incur a TSCI at a younger age lose substantially more life years, particularly those who incur complete 220 
tetraplegia. Reflecting the contracted LE of the Swiss SCI population, the measure of PYLL is an 221 
additional, population-referenced indicator of the individual burden associated with SCI. The apparent 222 
differential impact of lesion characteristics on PYLL in relation to age at injury could be in part due to 223 
the consequences of aging with a SCI. Such differentials in survival that go beyond normal aging have 224 
been evidenced in a previous study using data from the Swiss SCI population (Chamberlain et al. 225 
2018). Allostasis adaptation – or the biochemical, physiologic, and psychological changes undergone 226 
to maintain or restore homeostasis – in response to chronic disease may serve as a catalyst for 227 
accelerated aging (Juster et al. 2016; Shiels et al. 2017). Allostatic load (AL) – or the accumulative 228 
wear-and-tear on the body – has been liked to an increased risk of comorbidities as well as mortality, 229 
and is evidenced to be impacted by events across the life course, including traumatic events (e.g., 230 
child abuse), social (e.g., socioeconomic status), or even personality traits influencing stress response 231 
(Juster et al. 2016; Castagné et al. 2018). It is therefore conceivable that the physiological 232 
dysregulations associated with level and completeness of the spinal cord lesion contribute to the 233 
accumulation of AL with increasing time since injury, and importantly to the differential accumulation 234 
over time. In order to better understand the synergistic effect of time since injury on allostatic load,  and 235 
thereby identify targets for reducing AL and subsequent health outcome differentials, longitudinal 236 
studies are needed that investigate trajectories of biomarkers instrumental to the AL hypothesis (e.g., 237 
telomere length, parameters of immune function/immune senescence) and risk factors for increased 238 
AL across the life course of persons with SCI.  239 
In comparison to individuals who incurred an incomplete paraplegia, complete tetraplegia was 240 
associated with nearly seven times more excess deaths – or deaths beyond what is expected based 241 
on GP mortality rates. This is considerably higher than the roughly four-fold increase in risk of mortality 242 
estimated when using standard methods (i.e., methods not taking into account background GP 243 
mortality rates). Additionally, if considering solely standard hazard ratios, it would appear that the 244 
oldest age group (76 years and older) has by far the highest risk of mortality; however, when 245 
accounting for background mortality in the GP, the excess hazard is attenuated and similar to that of 246 
individuals between 61 and 75 years of age. Such information may change targets for interventions 247 
as, in the example of age, this points towards the need to equally target these two age groups in 248 
efforts to minimize or reduce premature mortality. When considering the elevated risk associated with 249 
complete tetraplegia, the further accentuation when accounting for background mortality in the GP 250 
points towards an influence of age and sex on lesion characteristics; i.e., younger individuals are more 251 
affected by complete tetraplegia. This suggests the need to potentially reassess and invest more 252 
resources towards reducing disparities in risk of premature mortality and to mitigate individual-level 253 
burden associated with lesion characteristics, particularly targeting younger individuals who have 254 
incurred a complete tetraplegia. Given that the burden associated with TSCIs is expected to augment 255 
in the future due to the projected increase in the incidence rate of TSCIs among older individuals 256 
primarily due to falls, refining and reevaluating high risk group definitions is essential to ensure the 257 
intended prevention or reduction of premature mortality (Ahn et al. 2017).  258 
 259 
Strengths & limitations 260 
Estimates of the contribution of pre-specified risk factors on all-cause mortality due to SCI can be 261 
misleading given the influence of the background mortality experienced by the general population. 262 
Therefore, a strength of this study is the provision of relative estimates of survival and mortality, which 263 
provide unbiased indicators of mortality due to sustaining a TSCI through standardization to the GP by 264 
age, sex, and decade. Although individuals within this study were included within the mortality rates for 265 
the GP, given that TSCI is rare the impact on estimates is negligible. A potential limitation of this study, 266 
however, is the limited follow-up time of roughly 20 years. At the end of the study period, the majority 267 
of individuals were still alive, therefore in order to model remaining life years, this study was forced to 268 
rely on model assumptions for estimation, for example restricting the maximum age to 90 years. 269 
Extended follow-up in the context of the SwiSCI cohort study will facilitate validation. Additionally, it 270 
was not possible to adequately investigate trends in LE or other mortality-related outcomes. Given the 271 
paucity and conflicting evidence on trends in improvements of mortality -related outcomes, country-272 
specific analyses are needed.  273 
 274 
Conclusion 275 
Population health indicators such as residual life expectancy, life years lost, relative survival and 276 
excess mortality can serve to inform health systems regarding burden and expected associated costs 277 
across the life course of individuals with a SCI. This study provides the first Swiss-specific estimates of 278 
PYLL and LYR after SCI; the two components needed for the calculation of disease-specific DALYs. 279 
This study further provides evidence of an extended LE following a TSCI, even for the most severe 280 
lesions, thereby justifying the provision of specialized care post-SCI to support improved long-term 281 
functioning and health. Furthermore, the estimates of relative survival and excess hazard ratios can be 282 
used for health policy and raising awareness of potential inadequacies in the continued care for 283 
persons with chronic TSCI.  284 
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Tables & Figures 310 
 311 
Table 1 Study characteristics according to vital status 312 
Those with a discharge destination of "Death" were discharged after study end (i.e., post -September 313 
30 2011).  314 
 315 
Table 2 Marginally adjusted estimates of life years remaining according to attained age  316 
Life years remaining (LYR) estimates stratified by injury severity exclude individuals who incurred a 317 
TSCI pre-2000.  318 
 319 
Table 3 Excess mortality per 1’000 person-years, stratified by lesion characteristics 320 
Excess mortality presented as the average excess mortality with 95% confidence intervals.  321 
 322 
Fig. 1 Potential years of life lost (PYLL) according to age at injury, stratified by lesion 323 
characteristics 324 
The solid black line indicates potential years of life lost (PYLL) for complete tetraplegic lesions, the 325 
dashed dark  grey line indicates PYLL for incomplete tetraplegic lesions, the dashed light grey line that 326 
for complete paraplegic lesions, and finally the solid light grey line the PYLL for incomplete paraplegic 327 
lesions.  328 
 329 
Fig. 2 Comparison of estimated hazard ratios and excess hazard ratios  330 
The unfilled circle represents the reference category. The black -filled circle corresponds to estimated 331 
hazard ratios (HR), while the grey-filled circle corresponds to the estimated excess hazard ratio (eHR). 332 
The 95% confidence intervals (95% CI) are represented by the solid lines on either side of the circle 333 
representing the HR or eHR. All estimates are adjusted for lesion level and completeness, attained 334 
age, and sex. To note, the left-hand y-axis corresponds to the HR and eHRs estimated for attained 335 
age; the right-hand y-axis corresponds to the HR and eHRs for all other variables.  336 
 337 
Fig. 3 Marginally adjusted survival and relative survival probabilities, stratified by lesion 338 
characteristics 339 
The solid black line indicates the marginally adjusted survival and relative survival probability for 340 
incomplete paraplegia; the dashed line that for complete paraplegia; the light grey, dotted line that for 341 
incomplete tetraplegia; and finally the dashed-dotted line for complete tetraplegia.342 
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Table 1. Study characteristics according to vital status 
Those with a discharge destination of "Death", but who are categorized as “Alive”, were discharged 
after study end (i.e., post-Sept 30 2011). * AIS scores are only available post-2000.  
Characteristics [missings] 
Alive 
N=1,907 
Dead 
N=379 
Missing Vital 
Status 
N=206 
Age at injury, years: mean; S.D. (IQR) 40.5; 17.2 (27) 62.6; 17.9 (26) 47.0; 20.2 (35.5) 
Length of stay, months: mean; S.D. 
(IQR) 
5.8; 7.8 (4.3) 4.9; 3.6 (5.1) 5.0; 4.2 (4.7) 
Sex [1]    
Male 1420 (74.5) 260 (68.6) 152 (73.8) 
Female 486 (25.5) 119 (31.4)  54 (26.2) 
Age at injury    
16-30 678 (35.8)  27 (7.2)  58 (28.6) 
31-45 527 (27.8)  44 (11.7)  46 (22.7) 
46-60 391 (20.6)  76 (20.2)  41 (20.2) 
61-75 233 (12.3) 122 (32.4)  34 (16.7) 
76+  67 (3.5) 108 (28.6)  24 (11.8) 
Etiology [2]    
Sports and leisure 501 (26.3)  41 (10.8)  20 (9.7) 
Transport 596 (31.3)  71 (18.8)  63 (30.6) 
Falls 602 (31.6) 209 (55.3)  92 (44.7) 
Other cause 207 (10.9)  57 (15.1)  31 (15.0) 
SCI Type [13]    
Tetra 1076 (56.7) 158 (41.8) 105 (52.0) 
Para 703 (37.0) 204 (54.0)  83 (41.1) 
Cauda equina 120 (6.3)  16 (4.2)  14 (6.9) 
Completeness [101]    
Complete 1264 (68.4) 234 (65.0) 130 (70.7) 
Incomplete 583 (31.6) 126 (35.0)  54 (29.3) 
Lesion Level & Completeness [56]    
Paraplegia, incomplete 638 (36.4)  85 (24.6)  60 (34.3) 
Paraplegia, complete 423 (24.1)  68 (19.7)  41 (23.4) 
Tetraplegia, incomplete 534 (30.5) 135 (39.0)  61 (34.9) 
Tetraplegia, complete 157 (9.0)  58 (16.8)  13 (7.4) 
AIS Score* [968]    
AIS A 372 (29.4)  57 (33.1)  20 (23.3) 
AIS B 149 (11.8)  27 (15.7)  11 (12.8) 
AIS C 194 (15.3)  41 (23.8)  18 (20.9) 
AIS D/E 551 (43.5)  47 (27.3)  37 (43.0) 
Injury Severity* [1,324]    
C1-C4 ABC  88 (8.6)  16 (15.8)  6 (12.5) 
C5-C8 ABC  86 (8.4)  11 (10.9)  1 (2.1) 
T1-S3 ABC 294 (28.9)  27 (26.7)  4 (8.3) 
AIS D/E 551 (54.1)  47 (46.5)  37 (77.1) 
Destination after discharge [75]    
Private residence 1612 (86.6) 164 (45.1) 131 (68.6) 
Hospital  78 (4.2)  45 (12.4)  19 (9.9) 
Nursing home/assisted living 154 (8.3)  86 (23.6)  39 (20.4) 
Other (e.g., hotel)  15 (0.8)  2 (0.5)  2 (1.0) 
Death  3 (0.2)  67 (18.4)  0 (0.0) 
Ventilator Assistance [74]    
No 1843 (98.0) 291 (85.8) 193 (97.5) 
Yes  38 (2.0)  48 (14.2)  5 (2.5) 
Table 2. Marginally adjusted estimates of life years remaining according to attained age 
Estimates adjusted for attained age, sex, level and lesion of spinal cord injury. Estimates according to 
AIS score are restricted to injuries that were incurred post-2000.  
  Attained age 
  30 40 50 60 
Sex         
Male 41.7 (37.9-45.5) 33.6 (30.0-37.2) 24.4 (22.2-26.6) 17.4 (14.8-19.9) 
Female 42.8 (40.1-45.5) 34.8 (32.3-37.2) 26.1 (23.5-28.6) 18.8 (16.4-21.1) 
SCI Type 
    
Para incomplete 45.1 (42.1-48.2) 36.4 (32.1-40.7) 27.3 (24.8-29.8) 20.6 (18.0-23.3) 
Para complete 40.4 (36.0-44.7) 32.5 (28.3-36.7) 23.5 (19.7-27.3) 16.3 (13.6-18.9) 
Tetra incomplete 42.8 (38.4-47.2) 34.6 (31.8-37.5) 25.4 (22.7-28.0) 17.6 (14.6-20.6) 
Tetra complete 28.7 (25.4-31.9) 21.7 (17.4-26.1) 13.6 (9.3-17.9) 9.8 (8.3-11.2) 
AIS  
    
All D/E 48.3 (43.0-53.6) 38.4 (34.4-42.4) 29.2 (26.1-32.3) 21.1 (17.1-25.1) 
C1-C4 ABC 37.0 (23.4-50.7) 26.8 (19.1-34.5) 18.7 (13.2-24.3) 13.4 (6.7-20.0) 
C5-C8 ABC 34.3 (26.2-42.4) 24.5 (17.7-31.3) 17.3 (10.9-23.7) 11.0 (7.7-14.3) 
T1-S5 ABC 41.4 (36.2-46.5) 31.6 (24.7-38.4) 23.9 (18.9-28.8) 16.8 (11.3-22.3) 
 
 
 
 
 
Table 3. Excess mortality per 1’000 person-years, stratified by lesion characteristics 
Excess mortality presented as the average excess mortality with 95% confidence intervals.  
 
Paraplegia Tetraplegia 
  Incomplete Complete Incomplete Complete 
Sex 
    Female 5.06 (2.01-12.93) 8.09 (3.39-19.68) 9.51 (3.76-24.51) 24.62 (11.00-56.12) 
Male 3.45 (1.43-8.53) 6.49 (2.98-14.54) 6.53 (2.90-15.08) 15.95 (7.55-34.61) 
Age     
16-30 0.55 (0.15-2.04) 1.33 (0.38-4.65) 0.71 (0.19-2.59) 3.59 (1.07-11.98) 
31-45 1.91 (0.79-4.61) 4.46 (2.14-9.33) 2.56 (1.07-6.15) 11.68 (5.64-24.30) 
46-60 3.19 (1.27-8.08) 7.53 (3.44-16.61) 4.62 (2.01-10.69) 20.86 (9.71-45.08) 
61-75 10.77 (4.83-24.16) 22.69 (10.85-47.78) 14.39 (6.94-30.00) 78.66 (39.56-157.24) 
76+ 13.02 (4.36-39.06) 29.12 (9.83-86.60) 19.06 (6.69-54.49) 102.34 (35.26-297.82) 
 
Figure 1. Potential years of life lost (PYLL) according to age at injury, stratified by lesion characteristics 
The solid black line indicates potential years of life lost (PYLL) for complete tetraplegic lesions, the dashed dark grey line indicates PYLL for incomplete tetraplegic 
lesions, the dashed light grey line that for complete paraplegic lesions, and finally the solid light grey line the PYLL for incomplete paraplegic lesions.  
 
Figure 2. Comparison of estimated hazard ratios and excess hazard ratios  
The unfilled circle represents the reference category. The black-filled circle corresponds to estimated hazard ratios (HR), while the grey-filled circle corresponds to 
the estimated excess hazard ratio (eHR). The 95% confidence intervals (95% CI) are represented by the solid lines on either side of the circle representing the HR or 
eHR. All estimates are adjusted for lesion level and completeness, attained age, and sex. To note, the left-hand y-axis corresponds to the HR and eHRs estimated 
for attained age; the right-hand y-axis corresponds to the HR and eHRs for all other variables.
 
 
 
Figure 3. Marginally adjusted survival and relative survival probabilities, stratified by lesion characteristics 
The solid black line indicates the marginally adjusted survival and relative survival probability for incomplete paraplegia; the dashed line that for complete 
paraplegia; the light grey, dotted line that for incomplete tetraplegia; and finally the dashed-dotted line for complete tetraplegia. 
 
